@article{920cc2e045f44fef93c6a6c0dc5c6d3d,
title = "Medicaid reimbursement rates for primary care services and behavioral health outcomes",
abstract = "We study the effects of changing Medicaid reimbursement rates for primary care services on behavioral health outcomes—defined here as mental illness and substance use disorders. Medicaid enrollees are at elevated risk for these, and other, chronic conditions and are likely to have unmet treatment needs. We apply two-way fixed-effects regressions to survey data specifically designed to measure behavioral health outcomes over the period 2010–2016. We find that higher primary care reimbursement rates reduce mental illness and substance use disorders among non-elderly adult Medicaid enrollees, although we interpret findings for substance use disorders with some caution as they may be vulnerable to differential pre-trends. Overall, our findings suggest positive spillovers from a policy designed to target primary care services to behavioral health outcomes.",
keywords = "healthcare, mental illness, public insurance, reimbursement, spillovers, substance use disorders",
author = "Maclean, {Johanna Catherine} and Chandler McClellan and Pesko, {Michael F.} and Daniel Polsky",
note = "Funding Information: Johanna Catherine Maclean and Michael F. Pesko were supported by a Research Scholar Grant—Insurance, RSGI–16–019‐01—CHIPS, from the American Cancer Society. We thank Steven Hill, Christina Marsh, Serena Phillips, Douglas Webber, and participants at the Southern Health Economics Study Group and Association for Public Policy and Management for helpful comments. We also thank Stephen Zuckerman for assistance with the data and Keisha Solomon for excellent research assistance. No official endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services is intended or should be inferred. All errors are our own. Funding Information: Johanna Catherine Maclean and Michael F. Pesko were supported by a Research Scholar Grant—Insurance, RSGI–16–019-01—CHIPS, from the American Cancer Society. We thank Steven Hill, Christina Marsh, Serena Phillips, Douglas Webber, and participants at the Southern Health Economics Study Group and Association for Public Policy and Management for helpful comments. We also thank Stephen Zuckerman for assistance with the data and Keisha Solomon for excellent research assistance. No official endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services is intended or should be inferred. All errors are our own. Publisher Copyright: {\textcopyright} 2023 John Wiley & Sons Ltd.",
year = "2023",
month = apr,
doi = "10.1002/hec.4646",
language = "English (US)",
volume = "32",
pages = "873--909",
journal = "Health Economics (United Kingdom)",
issn = "1057-9230",
publisher = "John Wiley and Sons Ltd",
number = "4",
}